ACR: Long-Term Safety Demonstrated for Anifrolumab in Lupus

MONDAY, Nov. 21, 2022 -- For patients with systemic lupus erythematosus (SLE), anifrolumab is safe in the long term, according to a study published online Nov. 11 in Arthritis & Rheumatology to coincide with the annual meeting of the American...